NOVEL BIOMARKERS PREDICT WHETHER CANCER EMERGES IN ANTI-TIF1-G POSITIVE DM PATIENTS AT HIGH RISK FOR CANCER

被引：0
|
作者：
Casciola-Rosen, Livia [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2023年 / 41卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
IS-9
引用
收藏
页码：408 / 408
页数：1
相关论文
共 50 条
  • [1] ANTI-TIF1-G POSITIVE DERMATOMYOSITIS WITH SEVERE OROPHARYNGEAL INVOLVEMENT AFTER IMMUNE CHECKPOINT INHIBITORS
    Tonutti, A.
    Luciano, N.
    Ceribelli, A.
    Sonaglia, A.
    Renna, D.
    Repici, A.
    Lania, A.
    Lleo, A.
    De Nicola, S.
    Bussini, L.
    Morelli, P.
    Pagani, M.
    Selmi, C.
    De Santis, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 558 - 558
  • [2] Cancer risk associated with anti-TIF1 antibodies
    Collison J.
    Nature Reviews Rheumatology, 2019, 15 (2) : 64 - 64
  • [3] Novel biomarkers that predict survival in patients with ovarian cancer
    Hogdall, E. V., Sr.
    Nedergaard, L.
    Engelholm, S. A.
    Lundvall, L.
    Petri, A. L.
    Risum, S.
    Hogdall, C. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Analysis of the risk of cancer among myositis patients without anti-TIF1-γ OR -HMGCR antibodies
    Unuma, A.
    Kadoya, M.
    Hida, A.
    Taira, K.
    Uchio, N.
    Ikenaga, C.
    Kubota, A.
    Tsuji, S.
    Shimizu, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 268 - 268
  • [5] Myopathological features of cancer-free myositis with anti-TIF1-γ-Ab positive
    Taira, Kenichiro
    Uchio, Naohiro
    Unuma, Atsushi
    Kadoya, Masato
    Ikenaga, Chiseko
    Kubota, Akatsuki
    Shimizu, Jun
    Toda, Tatsushi
    BRAIN PATHOLOGY, 2019, 29 : 32 - 32
  • [6] Computational Analysis Identifies Novel Biomarkers for High-Risk Bladder Cancer Patients
    Piliszek, Radoslaw
    Brozyna, Anna A.
    Rudnicki, Witold R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [7] Anti-TIF1-γ antibody-positive dermatomyositis caused by camrelizumab in a patient with oesophageal cancer
    Li, J.
    Yi, S.
    Huang, Y.
    Peng, Y.
    Yang, Z.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 395 - 395
  • [8] Clinical and laboratory parameters predicting cancer in dermatomyositis patients with anti-TIF1γ antibodies
    Nhung Thi My Ly
    Ma, Ni
    Ueda-Hayakawa, Ikuko
    Chuyen Thi Hong Nguyen
    Anada, Reiko
    Okamoto, Hiroyuki
    Fujimoto, Manabu
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2021, 104 (03) : 177 - 184
  • [9] EFFECTIVE IMMUNOTHERAPY OF ANTI-TIF1-GAMMA-POSITIVE PARANEOPLASTIC DERMATOMYOSITIS WITH CONCURRENT DIAGNOSIS OF OVARIAN CANCER
    Jazebi, Noushin
    Shanina, Elena
    MUSCLE & NERVE, 2019, 60 : S71 - S71
  • [10] A NOVEL NOMOGRAM TO PREDICT POSTOPERATIVE BIOCHEMICAL RECURRENCE IN PATIENTS WITH LOCALIZED HIGH-RISK PROSTATE CANCER
    Alam, Ridwan
    Tosoian, Jeffrey J.
    Nyame, Yaw A.
    Wilkins, Lamont
    Yousefi, Kasra
    Chappidi, Meera R.
    Reddy, Chandana A.
    Humphreys, Elizabeth B.
    Sundi, Debasish
    Chapin, Brian F.
    Stephenson, Andrew J.
    Klein, Eric A.
    Ross, Ashley E.
    JOURNAL OF UROLOGY, 2017, 197 (04): : E130 - E131
12345